Evidence map›Paper›PMID 41649772›Full record

ReviewClinical pharmacokinetics2026

β-Lactam Antibiotics in Obese Adults: A Review of Population Pharmacokinetic Analyses.

Guiva Annane, Benoît Crevier, Anis Ouyahia, Amélie Marsot

Abstract readReview
PubMed Publisher
In one paragraph

Review in Clinical pharmacokinetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Guiva AnnaneLaboratoire STP2, Faculté de Pharmacie, Université de Montréal, Montréal, QC, Canada. guiva.annane@umontreal.ca.
Benoît CrevierCISSS de la Montérégie-Centre, Hôpital Charles-Le Moyne, Greenfield Park, QC, Canada.ORCID 0000-0002-1837-1585
Anis OuyahiaCISSS de la Montérégie-Centre, Hôpital Charles-Le Moyne, Greenfield Park, QC, Canada.
Amélie MarsotLaboratoire STP2, Faculté de Pharmacie, Université de Montréal, Montréal, QC, Canada.ORCID 0000-0002-9303-8862

Funding

Fonds de Recherche du Québec - Santé 365243
6 · The paper itself

Abstract

Obesity is becoming more prevalent, and it significantly alters drug pharmacokinetics (PK), potentially impacting the efficacy and safety of β-lactam antibiotics. Population pharmacokinetic (popPK) modeling plays a crucial role in optimizing dosing strategies, yet there is variability in how these models account for obesity-related physiological changes. This review aims to synthesize published popPK studies on β-lactams in obese populations, highlighting key findings and modeling approaches. A literature review was conducted to identify popPK studies evaluating β-lactam antibiotics in obese individuals. Relevant databases were searched for studies reporting PK parameters, covariates, and dosing recommendations. A total of 24 studies met the predefined selection criteria. The majority employed two-compartment models with creatinine clearance (CL

Indexed as

Anti-Bacterial Agentsbeta Lactam Antibioticsbeta-LactamsModels, BiologicalObesityAdultHumansAnti-Bacterial Agentsbeta Lactam Antibioticsbeta-Lactams

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.